Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

630 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis.
Saint-Martin F, Dumur JP, Pérez I, Izquierdo I; French Rupatadine-Rhinitis Study Group. Saint-Martin F, et al. Among authors: izquierdo i. J Investig Allergol Clin Immunol. 2004;14(1):34-40. J Investig Allergol Clin Immunol. 2004. PMID: 15160440 Clinical Trial.
Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a multicentre, double-blind, randomized, comparative clinical trial with bifonazole 1% cream. Efficacy of flutrimazole 1% dermal cream in dermatomycoses. Catalan Flutrimazole Study Group.
Alomar A, Videla S, Delgadillo J, Gich I, Izquierdo I, Forn J. Alomar A, et al. Among authors: izquierdo i. Dermatology. 1995;190(4):295-300. doi: 10.1159/000246720. Dermatology. 1995. PMID: 7655109 Clinical Trial.
ESPRINT-15 questionnaire (Spanish version): reference values according to disease severity using both the original and the modified ARIA classifications.
Valero A, Izquierdo I, Sastre J, Navarro AM, Baró E, Martí-Guadaño E, Ferrer M, Dávila I, del Cuvillo A, Colás C, Antépara I, Alonso J, Mullol J; ESPRINT Study Group. Valero A, et al. Among authors: izquierdo i. J Investig Allergol Clin Immunol. 2013;23(1):14-9. J Investig Allergol Clin Immunol. 2013. PMID: 23653969 Free article.
630 results